Legal Representation
Attorney
Bryce J. Maynard
USPTO Deadlines
Application History
45 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 30, 2025 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Jun 30, 2025 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Apr 1, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 1, 2025 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| Apr 1, 2025 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 1, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Jan 31, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Nov 15, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Nov 15, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
| May 17, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 16, 2024 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| May 16, 2024 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| May 16, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 17, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 15, 2023 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Nov 15, 2023 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Nov 15, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 17, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 15, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| May 15, 2023 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| May 15, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 18, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 16, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 16, 2022 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Nov 16, 2022 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jul 13, 2022 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| May 18, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 16, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| May 16, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| May 16, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 16, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 21, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 21, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 1, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 17, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 16, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 16, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 12, 2021 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Aug 9, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 16, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 16, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 16, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 8, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 31, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 6, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Medicinal signal cells for scientific and research purposes
First Use Anywhere:
Jun 23, 2021
First Use in Commerce:
Jun 23, 2021
Class 005
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medicinal signal cells for medical and veterinary use; pharmaceutical and veterinary preparations for the treatment of frailty in humans and animals
First Use Anywhere:
Jun 23, 2021
First Use in Commerce:
Jun 23, 2021
Class 042
Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Scientific research services involving medicinal stem cells
First Use Anywhere:
Jun 23, 2021
First Use in Commerce:
Jun 23, 2021
Classification
International Classes
001
005
042